Taylor Takla, a Ph.D. candidate in the translational neuroscience program in Wayne State University's School of Medicine, recently received a...
Vous n'êtes pas connecté
A new consortium co-led by Weill Cornell Medicine, has been awarded a five-year, $31 million grant from the National Institutes of Health's National Institute of Allergy and Infectious Diseases to accelerate the development of faster, more effective treatment regimens for tuberculosis (TB).
Taylor Takla, a Ph.D. candidate in the translational neuroscience program in Wayne State University's School of Medicine, recently received a...
An iron-binding drug that is already approved for treatment of other diseases could provide a novel way to attack ovarian tumours, according to a new...
August 14, 2024 -- Two National Institutes of Health (NIH)-supported trials of an experimental malaria vaccine in healthy Malian adults found that all...
MELBOURNE, Australia, Aug. 14, 2024. Prota Therapeutics Pty Ltd (Prota), an Australian clinical-stage biotechnology company focused on the development...
INSTITUTE OF HUMAN VIROLOGY, NIGERIA INVITATION TO BID BID TITLE SUPPLY OF TOOLS FOR TB FIELD WORKERS UNDER GF N-THRIP GRANT 1. INTRODUCTION: The...
New advances in screening, prevention and treatment of TB make tremendous progress possible — if we tap them.
The Institute for Population Health (IPH) of Weill Cornell Medicine-Qatar (WCM-Q) organized a workshop on the fundamentals of health research for 49...
The National Institute of General Medical Sciences, a branch of the National Institutes of Health (NIH), has awarded Yubing Sun, associate professor...
August 14, 2024 -- Researchers at the National Institutes of Health’s (NIH) Clinical Center and the National Heart, Lung and Blood Institute...